Wed, November 4, 2020
Tue, November 3, 2020
Mon, November 2, 2020
Sun, November 1, 2020
Fri, October 30, 2020
Thu, October 29, 2020
Wed, October 28, 2020

David Lebovitz Downgraded (BPMC) to Hold on, Oct 30th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. tz-downgraded-bpmc-to-hold-on-oct-30th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Downgraded "Blueprint Medicines Corporation" (BPMC) to Hold on, Oct 30th, 2020.

David has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 0 agree with David's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with David


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $120 on, Thursday, October 29th, 2020
  • Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $122 on, Friday, October 16th, 2020
  • Andrew Berens of "Morgan Stanley" Maintained at Buy with Increased Target to $100 on, Tuesday, October 13th, 2020
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $110 on, Wednesday, July 15th, 2020

Publication Contributing Sources